Form 4: Replimune Officer Sells Shares for Tax Withholding

Replimune Group Inc. reports a Form 4 filing detailing a transaction by Chief Commercial Officer Christopher Sarchi involving the sale of common stock to cover tax withholding obligations.

Summary

• Christopher Sarchi, Chief Commercial Officer of Replimune Group, Inc., engaged in a transaction on May 18, 2026.
• The transaction involved the sale of 8,626 shares of common stock.
• These shares were sold to cover tax withholding obligations related to the partial vesting of Restricted Stock Units (RSUs).
• The sale was executed under an irrevocable 'sell to cover' provision within the RSU award agreements, not as a discretionary sale.
• The weighted average sale price was $5.08 per share, with individual sales ranging from $5.02 to $5.08.
• Following this transaction, Mr. Sarchi beneficially owns 192,962 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a standard, non-discretionary event related to tax obligations on vested equity awards.

Positives

• The sale was conducted under a pre-arranged, irrevocable 'sell to cover' plan, indicating it was not a discretionary decision by management to divest shares.
• The transaction is a standard procedure for covering tax liabilities associated with equity awards, suggesting no underlying negative sentiment from the reporting person.

Negatives

• A total of 8,626 shares were sold, representing a reduction in the reporting person's direct beneficial ownership.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it pertains to a specific insider transaction.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. The 'sell to cover' mechanism for tax withholding is a common and accepted practice in the biotechnology and pharmaceutical sectors, where equity-based compensation is prevalent.

Stakeholder Impact

• Shareholders: The sale is a routine tax-related event and is not expected to have a significant impact on the share price or company operations. It does not reflect a change in the reporting person's fundamental view of the company's prospects.

Key Dates

Keywords

Form 4, SEC Filing, Replimune Group, REPL, Christopher Sarchi, Chief Commercial Officer, Stock Sale, Tax Withholding, Restricted Stock Units, RSU Vesting, Beneficial Ownership